Mahmoud Mirmehrabi

USPTO Granted Patents = 15 (Patent Applications = 11)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

Ayer, MA (US) (2017)
Halifax, CA (2015 - 2024)

Company Filing History:

4 out of 834

Johnson Matthey Public Limited Company

patents

3 out of 183

Ptc Therapeutics, Inc.

patents

2 out of 30

Crinetics Pharmaceuticals, Inc.

patents

4. 1 out of 13

Bioelectron Technology Corporation

patents

5. 1 out of 96

Agios Pharmaceuticals, Inc.

Amag Pharmaceuticals, Inc.

Years Active: 2015-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11938101 - Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide (2024-03-26),

2. 11304914 - Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide (2022-04-19),

3. 11254652 - Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide (2022-02-22),

4. 10889561 - Process of making somatostatin modulators (2021-01-12),

5. 10751302 - Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide (2020-08-25),

6. 10556922 - Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate (2020-02-11),

7. 10464918 - Process of making somatostatin modulators (2019-11-05),

8. 10251847 - Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide (2019-04-09),

9. 9918979 - Process of preparing low ABUK oxymorphone hydrochloride (2018-03-20),

10. 9815844 - Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same (2017-11-14),

11. 9682988 - [object Object] (2017-06-20),

12. 9567288 - Crystalline salts of (Z)-O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate (2017-02-14),

13. 9428516 - Crystalline forms of morphine sulfate (2016-08-30),

14. 9145420 - Crystalline forms of morphine sulfate (2015-09-29),

15. 9062063 - Forms of oxymorphone hydrochloride (2015-06-23),

Title: The Innovative Contributions of Mahmoud Mirmehrabi

Introduction

Mahmoud Mirmehrabi is a notable inventor based in Halifax, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of polymorphic forms of compounds that address various oxidative stress disorders. With a total of 15 patents to his name, Mirmehrabi's work is recognized for its potential impact on treating neurodegenerative diseases and other health conditions.

Latest Patents

Among his latest patents, Mirmehrabi has disclosed polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide. These forms include anhydrate, hydrate, and solvates, which are crucial for developing treatments for oxidative stress disorders, mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases, and diseases of aging. The methods of making these polymorphic and amorphous forms are also detailed in his patents, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Throughout his career, Mirmehrabi has worked with prominent companies in the pharmaceutical industry, including Johnson Matthey Public Limited Company and PTC Therapeutics, Inc. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Mirmehrabi has collaborated with notable professionals in his field, including Paul Mollard and Peter Giannousis. These collaborations have likely enhanced his research and development efforts, leading to the successful patenting of his innovative ideas.

Conclusion

Mahmoud Mirmehrabi's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in treating various health disorders.

This text is generated by artificial intelligence and may not be accurate.